Christine Bahls


Value Risk and Reward: Taking Stock of Value-Based Contracts in Pharma

A look at how VBC agreements between drug manufacturers and payers—which reimburse for pre-specified treatment outcomes—have measured up so far in reducing healthcare costs, and the opportunities still untapped to drive true value for both sides and the patients they serve.